Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2024 call → NOThe question asks whether management explains the company's forward direction by narrating what its counterparties are themselves doing and scaling — i.e., whether a substantial part of the forward account consists of reporting on the growth/expansion/ramp of specific customers, partners, etc. that the company already supplies, such that the company's own coming volume is presented as a consequence of those parties' trajectories. Let me review the transcript. The management (Andy Harmening, Derek Meyer, Pat Ahern) discusses: - Their own strategic plan, Phase 2, hiring RMs, product launches, digital upgrades. - Loan growth in auto, C&I, deposits. - Credit quality, CRE portfolio. - Guidance for loan growth, deposit growth, NII growth. Do they narrate counterparties' own trajectories? They mention "our prime/super prime auto portfolio" growth, "emerging C&I growth" — but these are their own loan categories, not specific counterparties' expansions. They mention "our customers continue to explore investments" — general. They mention "our commercial customers" generally. They mention "we added $215 million in auto balances" — that's their own portfolio. They don't describe specific customers, partners, licensees, distributors, payers, operators, or programs that they already supply, and narrate those parties' own ramps as the driver of the company's coming activity. The forward account is driven by their own initiatives (hiring, product launches, Phase 2), their own balance sheet remixing, and macro conditions. They don't say "our lead customer is building X, which will drive our volumes." The counterparties mentioned are generic customers, not identifiable parties with their own trajectories. The direction of explanation is the company's own actions, not somebody else's growth. So the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.